Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Clinical trial NCT05073744 · UNKNOWN

Trial details

NCT number: NCT05073744
Sponsor: Zhongda Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Nalbuphine Allergy Ablation Safety

Start date: 2021-09-05
Primary completion: 2023-08-31
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.